Profile
BDXB ISRG BDXA BDX ALC RMD
Company Name Becton, Dickinson and Company Intuitive Surgical, Inc. Becton, Dickinson and Company Becton, Dickinson and Company Alcon Inc. ResMed Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $13.69B $192.04B $55.91B $53.26B $37.61B $37.14B
Employees 77.00K 15.64K 0.00K 70.00K 25.60K 9.98K
CEO Thomas E. Polen Jr. Gary S. Guthart - Thomas E. Polen Jr. David J. Endicott Michael J. Farrell BE, MBA, SM
Ratings
BDXB ISRG BDXA BDX ALC RMD
Quant Rating Score 4 3 5 3 3 4
Quant Rating Buy Neutral Strong Buy Neutral Neutral Buy
Trading
BDXB ISRG BDXA BDX ALC RMD
Last Close $48.16 $537.59 $59.24 $181.52 $73.6 $253.62
High 52 $48.16 $610.45 $59.24 $249.08 $98.3 $293.73
Low 52 $48.16 $429.59 $59.24 $165.15 $72.05 $204.58
Price vs. 52 Week High 0 % -11.94 % 0 % -27.12 % -25.13 % -13.66 %
Price vs. 52 Week Low 0 % 25.14 % 0 % 9.91 % 2.15 % 23.97 %
Total Return
BDXB ISRG BDXA BDX ALC RMD
1 Month Return 0 % 20.2 % 0 % -3.02 % -1.21 % -7.35 %
3 Month Return 0 % 7.41 % 0 % -0.01 % -17.49 % -8.58 %
6 Month Return 0 % 4.05 % 0 % -12.35 % -24.69 % 7.09 %
9 Month Return 0 % -7.34 % 0 % -26.95 % -20.28 % -1.56 %
YTD Return 0 % 2.99 % 0 % -19.99 % -13.3 % 10.9 %
1 Year Return 0 % 4.64 % 0 % -23.28 % -21.09 % 4.36 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
BDXB ISRG BDXA BDX ALC RMD
Dividend Yield Percentage (TTM) 2.22 % - 2.26 % 2.24 % 0.44 % 0.86 %
Dividend Paid and Capex Coverage Ration (TTM) 1.73 % 4.3 % 1.73 % 1.73 % 3.26 % 4.34 %
Dividend Per Share (TTM) 4.16 % - 4.16 % 4.16 % 0.33 % 2.19 %
Payout Ratio (TTM) 73.1 % - 73.1 % 73.1 % 15.71 % 22.19 %
Growth
BDXB ISRG BDXA BDX ALC RMD
Asset Growth 8.54 % 8.54 %
Gross Profit Growth 11.69 % 11.69 %
Revenue Growth 4.16 % 4.16 %
Revenue 3 Year 5.3 % 5.3 %
Revenue 5 Year 8.72 % 8.72 %
Revenue 10 Year 59.37 % 59.37 %
EBIT Growth 19.82 % 19.82 %
Net Income Growth 14.89 % 14.89 %
Net Income 3 Yeari Growth Per Share -18.63 % -18.63 %
Net Income 5 Yeari Growth Per Share 28.82 % 28.82 %
Net Income 10 Yeari Growth Per Share -4.02 % -4.02 %
Operating Income Growth 13.55 % 13.55 %
Operating Cash Flow Growth (CFG) 27.07 % 27.07 %
Operating 3 Year CFG -18.4 % -18.4 %
Operating 5 Year CFG 6.25 % 6.25 %
Operating 10 Year CFG 45.28 % 45.28 %
EPS Growth 18.31 % 18.31 %
EPS Diluted Growth 18.62 % 18.62 %
Book Value Per Share -0.85 % -0.85 %
Share Holder 3 Year Equity Growth Per Share 9.16 % 9.16 %
Share Holder 5 Year Equity Growth Per Share 14.4 % 14.4 %
Share Holder 10 Year Equity Growth Per Share 241.78 % 241.78 %
Dividend Per Share Growth -2.44 % -2.44 %
Dividend 3 Year Growth Per Share 4.79 % 4.79 %
Dividend 5 Year Growth Per Share 4.14 % 4.14 %
Dividend 10 Year Growth Per Share 74.3 % 74.3 %
Debt Growth 31.74 % 31.74 %
Free Cash Flow Growth 45.25 % 45.25 %
Updated On 30 Sep 2024 30 Sep 2024
Profitability
BDXB ISRG BDXA BDX ALC RMD
Gross Profit Margin TTM 45.08 % 66.41 % 45.08 % 45.08 % 55.13 % 59.36 %
Return on Assets TTM 2.93 % 14.19 % 2.93 % 2.93 % 3.42 % 17.14 %
Return on Equity TTM 6.31 % 16.08 % 6.31 % 6.31 % 4.93 % 25.51 %
Return on Capital Employed TTM 5.78 % 16.05 % 5.78 % 5.78 % 4.98 % 23.55 %
Net Income Per EBT TTM 83.91 % 86.77 % 83.91 % 83.91 % 85.57 % 83.5 %
EBT Per Ebit TTM 70.86 % 112.41 % 70.86 % 70.86 % 86.96 % 99.54 %
EBIT Per Revenue TTM 12.63 % 29.3 % 12.63 % 12.63 % 14.38 % 32.75 %
Cash Flow To Debt Ratio TTM 16.82 % - 16.82 % 16.82 % 39.27 % 198.52 %
Receivables Turnover TTM 7.27 7.63 7.27 7.27 4.98 5.48
Payables Turnover TTM 1.85 11.09 1.85 1.85 5.03 7.52
Inventory Turnover TTM 2.97 1.81 2.97 2.97 1.88 2.25
Fixed Asset Turnover TTM 313.67 % 186.61 % 313.67 % 313.67 % 197.54 % 716.47 %
Asset Turnover TTM 38.95 % 49.67 % 38.95 % 38.95 % 31.94 % 62.96 %
Operating Cash Flow Per Share TTM 11.3 8.3 11.3 11.3 4.16 11.96
Free Cash Flow Per Share TTM 8.85 6.37 8.85 8.85 3.23 11.32
Cash Per Share TTM 262.85 % 1376.56 % 262.85 % 262.85 % 284.33 % 825.72 %
Operating Cash Flow Sales Ratio TTM 15.22 % 30.8 % 15.22 % 15.22 % 20.57 % 34.04 %
Free Cash Flow Operating Cash Flow Ratio TTM 78.37 % 76.72 % 78.37 % 78.37 % 77.51 % 94.7 %
Cash Flow Coverage Ratios TTM 16.82 % - 16.82 % 16.82 % 39.27 % 198.52 %
Price To Free Cash Flows Ratio TTM 21.02 84.55 20.71 20.89 23.53 22.39
Price To Operating Cash Flows Ratio TTM 16.55 64.75 16.3 16.45 18.27 21.21
Price Cash Flow Ratio TTM 16.55 64.75 16.3 16.45 18.27 21.21
Income Statement (TTM)
BDXB ISRG BDXA BDX ALC RMD
Revenue $20.18B $8.35B $20.18B $20.18B $9.91B $5.15B
Gross Profit $9.13B $5.63B $9.13B $9.13B $5.51B $3.05B
Gross Profit Ratio 45.22% 67.46% 45.22% 45.22% 55.61% 59.36%
EBITDA $4.82B $2.81B $4.82B $4.82B $2.68B $1.91B
Net Income $1.71B $2.32B $1.71B $1.71B $1.02B $1.4B
EPS Diluted 5.86 6.42 5.86 5.86 2.05 9.51
Balance Sheet (MRQ)
BDXB ISRG BDXA BDX ALC RMD
Long Term Debt $18.61B $0.11B $18.61B $18.61B $4.97B $0.81B
Total Liabilities $31.4B $2.31B $31.4B $31.4B $8.79B $2.21B
Total Equity $25.89B $16.53B $25.89B $25.89B $21.55B $5.97B
Total Investments $0.45B $7.05B $0.45B $0.45B $0.91B $0.09B
Total Debt $20.92B $0.15B $20.92B $20.92B $5.14B $0.88B
Total Assets $57.29B $18.84B $57.29B $57.29B $30.35B $8.17B
Cash Flow Statement (TTM)
BDXB ISRG BDXA BDX ALC RMD
Net Income $1.71B $2.34B $1.71B $1.71B $1.02B $1.4B
Inventory $0.1B $-0.83B $0.1B $0.1B $-0.05B $-0.08B
Dividends Paid $-1.1B $0B $-1.1B $-1.1B $-0.13B $-0.31B
Operating Cash Flow $3.8B $2.42B $3.8B $3.8B $2.08B $1.75B
Capital Expenditure $-0.73B $-1.11B $-0.73B $-0.73B $-0.67B $-0.09B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.29
ALC Alcon Inc. 74.25
ANGO AngioDynamics, Inc. 12.135
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 124.26
ATRC AtriCure, Inc. 34.07
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AVTR Avantor, Inc. 11.05
AZTA Azenta, Inc. 29.91
BAX Baxter International Inc. 19.175
BDX Becton, Dickinson and Company 179.285
BDXA Becton, Dickinson and Company 59.24
BLCO Bausch + Lomb Corporation 15.155
BLFS BioLife Solutions, Inc. 26.91
COO The Cooper Companies, Inc. 70.1
DXR Daxor Corporation 13.36
EKSO Ekso Bionics Holdings, Inc. 5.09
FEMY Femasys Inc. 0.6185
ETFs With Exposure to BDXB
Ticker ETF Name Weight Percentage Price
FCVT First Trust SSI Strategic Convertible Securities ETF 0.39 44.125
HSUN Hartford Sustainable Income ETF 0.134074 33.534
QPFF American Century Quality Preferred ETF 0.68 35.701
Unlock